Skip to main content

previous disabled Page of 9
and
  1. Article

    Open Access

    Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma

    Epidermal growth factor receptor (EGFR) is reportedly overexpressed in most esophageal squamous cell carcinoma (ESCC) patients, but anti-EGFR treatments offer limited survival benefits. Our preclinical data sh...

    Yanni Wang, Chang Liu, Huan Chen, ** Jiao in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma

    Lung adenocarcinoma (LUAD) patients have a dismal survival rate because of cancer metastasis and drug resistance. The study aims to identify the genes that concurrently modulate EMT, metastasis and EGFR-TKI re...

    Weina Fan, Ying **ng, Shi Yan, Wei Liu, **feng Ning in Cancer Cell International (2024)

  3. Article

    Open Access

    Tunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I study

    Tunlametinib (HL-085) is a novel, highly selective MEK inhibitor with substantial clinical activities in patients with NRAS-mutant melanoma. This phase I study evaluated the safety and preliminary efficacy of tun...

    Yuankai Shi, **aohong Han, Qian Zhao, YuLong Zheng in Experimental Hematology & Oncology (2024)

  4. No Access

    Article

    Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

    Claudin18.2 (CLDN18.2) is highly expressed with the development of various malignant tumors, especially gastrointestinal cancers, and is emerging as a new target for cancer treatment. Satricabtagene autoleucel...

    Changsong Qi, Chang Liu, Jifang Gong, Dan Liu, **cheng Wang in Nature Medicine (2024)

  5. Article

    Open Access

    Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection

    The immunoprotective components control COVID-19 disease severity, as well as long-term adaptive immunity maintenance and subsequent reinfection risk discrepancies across initial COVID-19 severity, remain uncl...

    Gang Yang, **peng Cao, Jian Qin, **nyue Mei in Signal Transduction and Targeted Therapy (2024)

  6. Article

    Open Access

    The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis

    Despite the success of PD-1 blockade in recurrent/metastatic nasopharyngeal carcinoma (NPC), its effect for locoregionally advanced NPC (LANPC) remains unclear. This study aimed to evaluate the benefit of addi...

    Ya-Nan **, Meng-Yun Qiang, Ying Wang, Yu-**g Lin in Cancer Immunology, Immunotherapy (2024)

  7. Article

    Open Access

    Polymorphism rs2327430 in TCF21 predicts the risk and prognosis of gastric cancer by affecting the binding between TFAP2A and TCF21

    Single nuclear polymorphisms (SNPs) have been published to be correlated with multiple diseases. Transcription Factor 21 (TCF21) is a critical transcription factor involved in various types of cancers. However...

    **nyi Zhou, Kuan Shen, Shuqing Cao, Pengyu Li, Jian **ao in Cancer Cell International (2024)

  8. No Access

    Article

    Functional dissection of human cardiac enhancers and noncoding de novo variants in congenital heart disease

    Rare coding mutations cause ∼45% of congenital heart disease (CHD). Noncoding mutations that perturb cis-regulatory elements (CREs) likely contribute to the remaining cases, but their identification has been prob...

    Feng **ao, **aoran Zhang, Sarah U. Morton, Seong Won Kim, Youfei Fan in Nature Genetics (2024)

  9. Article

    Open Access

    Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial

    This study aimed to evaluate the prognostic role of the baseline neutrophil/lymphocyte ratio (NLR) in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab/pertuzumab.

    Nianhua Ding, Jian Pang, Xuan Liu, **ongbin He, Wei Zhou in Breast Cancer Research (2024)

  10. Article

    Retraction Note to: Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo

    Zhi-Dong Lv, Hai-Bo Wang, Qian Dong, Bin Kong in Molecular and Cellular Biochemistry (2024)

  11. Article

    Open Access

    Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2

    The aim of this study is to evaluate an AAV vector that can selectively target breast cancer cells and to investigate its specificity and anti-tumor effects on breast cancer cells both in vitro and in vivo, of...

    Ya-feng Lv, Hao Zhang, Zhi Cui, Cui-jiao Ma, Yu-ling Li, Hua Lu, Hong-yan Wu in BMC Cancer (2023)

  12. Article

    Open Access

    Retraction Note: 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells

    Qi Wen, Chang Xu, Jie Zhou, Nuo-Min Liu, Ying-Hong Cui, Mei-Fang Quan in BMC Cancer (2023)

  13. Article

    Open Access

    Correction: UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expression of PDK1 through PI3K/AKT signaling

    Jian-**an Lin, **n-Sheng **e in Journal of Experimental & Clinical Cancer … (2023)

  14. Article

    Open Access

    CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling

    Chemoresistance is a major clinical challenge that leads to tumor metastasis and poor clinical outcome. The mechanisms underlying gastric cancer resistance to chemotherapy are still unclear.

    Long-Long Cao, Yu-Kai Wu, Tong-**n Lin, Mi Lin, Yu-**g Chen in Cancer Cell International (2023)

  15. No Access

    Article

    Evaluation of gut microbiota composition to screening for potential biomarker in AFB1-exposed sheep

    Aflatoxin B1 (AFB1) is an inevitable contaminant in animal feed and agricultural products, which seriously threatens the health of animals. However, there is currently no better diagnostic tool available than ...

    Luxi Lin, Pengfei Fu, Chaodong Zhang, Tingting Xu, Qinqin Cao, Aftab Shaukat in 3 Biotech (2023)

  16. Article

    Open Access

    Evaluation of dynamic recurrence risk for locally advanced gastric cancer in the clinical setting of adjuvant chemotherapy: a real-world study with IPTW-based conditional recurrence analysis

    The long-term dynamic recurrence hazard of locally advanced gastric cancer (LAGC) in the clinical setting of adjuvant chemotherapy (ACT) remains unclear.

    Dong Wu, Jun Lu, Zhen Xue, Qing Zhong, Bin-bin Xu, Hua-Long Zheng in BMC Cancer (2023)

  17. No Access

    Article

    The Aging Biomarker Consortium represents a new era for aging research in China

    Jie Ren, Moshi Song, Weiqi Zhang, Jian-** Cai, Feng Cao, Zhongwei Cao in Nature Medicine (2023)

  18. Article

    Open Access

    Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy

    An increasing amount of research has speculated that necroptosis could be a therapeutic strategy for treating cancer. However, understanding the prognostic value of the necroptosis-related long non-coding RNAs...

    Jianlan Liu, Binlin Luo, Pengpeng Zhang, Keyu Jiang, Zuoqiong Hou in BMC Cancer (2023)

  19. Article

    Open Access

    Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial

    Anaplastic lymphoma kinase (ALK) rearrangements are present in about 5–6% of non-small cell lung cancer (NSCLC) cases and associated with increased risks of central nervous system (CNS) involvement. Envonalkib...

    Yunpeng Yang, Jie Min, Nong Yang, Qitao Yu in Signal Transduction and Targeted Therapy (2023)

  20. Article

    Open Access

    High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA

    Normal high-density lipoprotein (nHDL) can induce angiogenesis in healthy individuals. However, HDL from patients with coronary artery disease undergoes various modifications, becomes dysfunctional (dHDL), and...

    Zhi-Wei Mo, Yue-Ming Peng, Yi-**n Zhang, Yan Li in Signal Transduction and Targeted Therapy (2023)

previous disabled Page of 9